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A recent editorial published by Terracini and Mirabelli in
the International Journal of Epidemiology1 addresses at
length the controversy on carcinogenicity of chrysotile as-
bestos and the need to ban all types of asbestos.1 Coupling
these themes with a critique of our 2012 review on tem-
poral aspects of asbestos exposure and risk of mesotheli-
oma2 is misleading, and conveys the message that we deny
the carcinogenic effects of asbestos exposure or try to influ-
ence asbestos regulations in less developed countries, two
false notions which are contradicted by the large body of
literature that we have produced over several decades,3–7
in particular on the carcinogenic effect of chrysotile.6,8
To attack anybody providing evidence falsifying prede-
fined conclusions: this appears to be the approach of Terra-
cini and Mirabelli,1 two authors not alien to the judiciary
system. Which kind of justice can be that evoked to generate
partisan wisdom, a justice which manipulates the truth and
forces the rules and guarantees of the legal system?
Science is good if it is capable of producing knowledge
which is unbiased, generated according to appropriate
methods, and therefore truthful. Any interference with the
legal system judiciary would bias the nature of the scien-
tific contribution, which is eminently cognitive. The evalu-
ation of scientific evidence in the legal setting belongs to a
different kingdom; those who generate and convey truthful
knowledge into the legal and judiciary process are bound
to the impartiality of the process. Failing to recognize the
independence of the two areas is dangerous venture; Ly-
senkoism is just one historical example of the use of false
science to support the legal persecution of innocents,
including dissenting scientists.9
Objectivity, impartiality and adherence to the highest
methodological standards have always driven our scientific
practice, as shown by the consistency in our production for
several decades. We stand behind any statement in our sci-
entific articles, including those expressed in our 2012 re-
view,2 which was portrayed by Terracini and Mirabelli as
example of ‘defence science’. We have represented our sci-
entific results across our career, as researchers, experts and
consultants for defence, plaintiff or court.
The statement by Terracini and Mirabelli,1 that the
formula proposed by Peto and other authors10—which
correlates the incidence of mesothelioma with the third or
fourth power of time since first exposure, in addition to
dose and type of fibre—does not imply that recent expos-
ure periods have little impact on incidence of the disease,
suggests a misunderstanding of the formula. Table 1 re-
ports some examples of the effect of avoiding the last 10
years of long-term exposure on the incidence estimated at
age 60 or 70, based on the formula, for exposures starting
at age 20. Avoiding the last 10 years of exposure reduces
the incidence of mesothelioma by less than 0.5% for ex-
posures present at the time of diagnosis, and by between
2% and 6% for exposures ending 10 years before diagno-
sis. One can refute the formula by Peto et al.10 and provide
evidence supporting alternative models of the relationship
between asbestos exposure and mesothelioma incidence
(which Terracini and Mirabelli do not do), but cannot ac-
cuse us of misinterpreting and misusing the formula (which
Terracini and Mirabelli do).
This is the third critique of our 2012 review published
by these authors,11-12 and we refer the interested reader to
our previous rebuttal of their arguments.13 That Terracini
and Mirabelli feel compelled to repeatedly resort to spe-
cious accusations that we are merely producing ‘defence
science’, only underscores their lack of ability to produce
substantive responses to our conclusions.
Indeed, our review2 which reviewed and discussed the
role of stopping exposure on long-term asbestos risk, pro-
vides the scientific rationale for continuing surveillance of
asbestos-exposed workers. Our conclusive sentences were:
‘Stopping exposure does not materially modify the risk of
mesothelioma over subsequent decades. This is the reason
for the still expanding mesothelioma epidemic across
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Europe,7,14 despite the appreciable decrease in exposure to
asbestos since the 1970s and the elimination of asbestos in
most European countries since the early 1990s’. These sen-
tences demonstrate our commitment to the study of the
tragic long-term public health effects of massive asbestos
use, even in countries which have eliminated asbestos
use for several decades now, with the ultimate goal
of producing solid evidence aimed at reducing the health
consequences of past asbestos exposure. Respectful dis-
agreement based on alternative interpretation of scientific
evidence is part of the scientific discourse and contributes
to advancement of knowledge, contrary to intentional mis-
representation of scientific findings, with or without the
goal of influencing the judiciary process.
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Table 1. Difference in incidence of mesothelioma estimated according to the model by Peto et al.10 in different scenarios of age
at last exposurea
Age at mesothelioma
incidence
Age at last
exposure: default
Age at last
exposure: alternativeb
Difference in estimated
incidence between default and alternative (%)
70 70 60 0.2
70 60 50 2.4
60 60 50 0.4
60 50 40 5.9
aAge at first exposure: 20 years; 4th power of temporal terms.
bIgnoring the last 10 years of exposure.
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